The Best Bond ETFs
Plus: Why Investors in Private Markets Need a Louder Voice, Add These Core Stocks to Your Buy List in 2026, and Why Managed-Futures Funds Are Here to Stay
Is this your brand on Milled? Claim it.
Morning DigestTori Brovet The fixed-income exchange-traded funds on this list earn Morningstar’s top rating for 2026. 
ADVERTISEMENT 
Editor's Picks 
Trends include ‘the debasement of the dollar,’ tailwinds for non-US stocks, and a collapse for the yen. Leslie Norton 
The founder and editor of Accredited Investor Insights on performance measurement, disclosure issues, and liquidity considerations for private equity and private credit. Jeffrey Ptak, Amy Arnott 
These portfolios’ hefty international stakes were additive (finally!). Christine Benz 
These undervalued stocks with wide economic moats and consistent cash flows look attractive. Susan Dziubinski Investing Insights Baron Opportunity Fund topped the list. Gabe Alpert For hyperscalers Microsoft, Meta Platforms, Alphabet, and Amazon, valuations may hinge more on future capital-expenditure guidance than earnings results. David Sekera, Susan Dziubinski, Jess Bebel One of the last of the true star mutual fund managers prepares to exit the stage. Robby Greengold These five relatively new actively managed ETFs caught our eye for their sound approaches and strong teams. David Carey We are holding off on changing stock valuations until rules are finalized. Julie Utterback We’ve raised our fair value estimate of Corning stock by nearly 60%, and have also raised our Uncertainty Rating. William Kerwin Recent Earnings New Stock Analyst Reports In the fourth quarter, Kimberly-Clark (KMB) posted 2% organic sales growth (including a 3% benefit from volume and mix, partially offset by 1% lower prices) against a 37% adjusted gross margin, flat with a year ago. Amid an intensely competitive and uncertain macro landscape, Kimberly is taking bold actions to position itself for long-term growth. This includes the pending spinoff of its international tissue business into a joint venture and its intended acquisition of Kenvue. While these moves should pivot the portfolio more toward faster-growing and higher-margin personal care, significant integration and litigation (around talc and Tylenol) risks lie ahead. New Fund Analyst Reports Transamerica International Equity’s (TRWAX) strengths are still intact, and it remains an appealing option for flexible value fans. The Tools You Need to Invest Like an Analyst Stay connected:
|
Unsubscribe from this newsletter. Or update your email preferences.
© 2026 Morningstar, Inc. All Rights Reserved. 22 W. Washington St. Chicago, IL 60602
